FINANCIALS

EYPT Eyepoint Pharmaceuticals Inc 1314102

Income Statement
Revenue	eypt-20241231	43,273,000
Net Income	eypt-20241231	-130,870,000
Profit Margin		-302.43%

Balance Sheet
Current Assets	383,306,000
Assets	418,465,000
Current Liabilities	49,048,000
Liabilities	81,964,000
Equity	336,501,000
Shares Out	83,432,000

Cash Flow Statement
Operating Cash Flow	-126,226,000
Investing Cash Flow	-219,355,000

Market Analysis
Market Cap	1,188,071,091
Price	14.24
BVPS	6.29
PB	0.97
EPS	-3.17
PS	3.28
FCF	-345,581,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view EYPT documents filed with the SEC.

EYPT Filings Clear

View A List of Tickers